HIF1A and cancer: At the cellular level, the activation of the transcription factor hypoxia-inducible factor 1 (HIF-1) [42], has been identified as a master regulator of the response of cancer cells to hypoxia, triggering the expression of multiple target genes contributing to angiogenesis, treatment failure, invasion/metastasis, altered metabolism and genomic instability [32, 43].